APC and Miyoshi myopathy: Given that in the TCGA SKCM cohort APC/CTNNB1 mutations are infrequent but have an adverse prognosis only in metastatic cutaneous melanoma, we sought to investigate their theragnostic significance in a much larger and more contemporary MM patient cohort with known APC/CTNNB1 mutations and measurable disease.